Ghana building collapse traps dozens, kills 1
















ACCRA, Ghana (AP) — A five-story shopping center built earlier this year in a bustling suburb of Ghana‘s capital collapsed Wednesday, killing at least one person and leaving several dozen people trapped in the rubble, authorities and eyewitnesses said.


Rescue crews used cranes to try and remove debris from the top of the building amid fears that machinery sifting through the wreckage could injure trapped survivors. Crowds of bystanders gathered as rescuers sifted through cement and glass.













The fatality at the Melcom Shopping Center at Achimota, a suburb of Accra, was confirmed by Public Affairs Officer of the Ghana Fire Service Billy Anaglate. “We are still working to find out the fate of others who may be trapped under,” he said.


Other officials told The Associated Press that the death toll was likely to rise.


An AP reporter at the scene saw at least one man pulled from the debris, covered in dust and who was then whisked into an ambulance.


A Greater Accra Regional Public Affairs officer, deputy superintendent Freeman Tettey, confirmed that one person died and told the AP that 51 have been rescued and sent to hospitals around the capital.


“I was on my way to the shop when l saw it crumpling down,” Kojo Boadi, an eyewitness, said.


President John Mahama declared the scene a disaster zone and cut short his election campaign in the north of the country to be able to visit the site. The presidential election is scheduled for December.


The five-story store opened in February is part of the Melcom chain owned by Indian immigrant magnate, Bhagwan Khubchandani. His late father arrived in Ghana in 1929 as a 14-year-old to work as a store boy in the-then Gold Coast.


The store sells a variety of cheap, imported household goods and appliances that are popular with working-class Ghanaians.


Africa News Headlines – Yahoo! News



Read More..

VICTORY TWEET


















Read More..

CBS’s ‘Elementary’ gets prized post-Super Bowl slot
















LOS ANGELES (TheWrap.com) – CBS’s freshman Sherlock Holmes drama “Elementary” will get a big boost in February, when it airs following Super Bowl XLVII, the network said Monday.


The series, which stars Jonny Lee Miller and Lucy Liu, delivers a modern-day take on the Sherlock Holmes saga, with both the detective and his sidekick Watson living in contemporary New York.













The special episode will air Sunday, February 3 at 10 p.m. ET/7 p.m. PT, following the network’s post-game coverage.


The series, which also stars Aidan Quinn, has already proven to be a hit for the network, regularly winning its Thursday at 10 p.m. timeslot. “Elementary,” which premiered September 27, has averaged a 3.5 rating/10 share in the advertiser-cherished 18-49 demographic, and 14.2 million total viewers.


Even so, the exposure that a post-Super Bowl slot provides certainly can’t hurt. The second-season premiere of NBC‘s “The Voice” after the Super Bowl, meanwhile, scored the highest ratings of any entertainment telecast since 2006.


“The Voice” scored a 16.3 rating in the key demo and 37.6 million total viewers overall. It was the best rating since a 16.5 for “Grey’s Anatomy” after the Super Bowl on ABC in 2006, and provided a welcome boost for fourth-place network NBC. The show was up 47 percent in the demo and 40 percent in total viewers over the episode of “Glee” that aired after the Super Bowl on Fox last year. (“Glee” scored an 11.1 and 26.8 million total viewers.)


The ratings victory gave “The Voice” a huge start to its second season. It spent much of 2011-12 neck-in-neck with the Wednesday night edition of “American Idol” to be the highest-rated show on television after “Sunday Night Football.” “Idol” ultimately beat “The Voice” on Wednesdays, but just barely.


The Super Bowl is typically the most-watched program of the year, and this year’s game set a record as the most-watched television program in U.S. history, with 111.3 million total viewers.


TV News Headlines – Yahoo! News



Read More..

Pfizer returns EU selling rights on Auxilium hand-disorder drug
















(Reuters) – Auxilium Inc ended a marketing deal for its hand-disorder drug with Pfizer Inc, regaining the rights to sell the drug in Europe, and pushed up its 2012 revenue forecast to reflect deferred revenue from the termination of the deal.


Pfizer, which had the right to negotiate marketing other Xiaflex indications in the European Union, will return the rights to the Dupuytren’s contracture treatment by April 24, 2013.













Auxilium, which is also testing Xiaflex to treat penile curvature, will record $ 94 million in deferred revenue. The drugmaker said it now expects between $ 153 million and $ 163 million in Xiaflex sales for 2012.


The company earlier expected Xiaflex sales of between $ 65 million and $ 77 million for the year. Sales of Xiaflex, called Xiapex in Europe, accounted for 22 percent of the company’s total sales in its third quarter.


Auxilium, which filed a marketing application with U.S. health regulators to sell Xiaflex to treat penile curvature on Wednesday, said it still expects 2012 to be its first profitable year.


(Reporting by Vidya P L Nathan; Editing by Joyjeet Das)


Health News Headlines – Yahoo! News



Read More..

Markets brush off Obama win amid gridlock concerns
















LONDON (AP) — The re-election of President Barack Obama gave markets a short-lived boost Wednesday, before concerns over his ability to get a budget agreement from a divided Congress and more grim economic news out of Europe turned sentiment around.


Obama easily clinched a majority in the electoral college, holding on to a raft of key swing states in Tuesday’s vote — despite only just winning the popular vote over his rival Mitt Romney.













Though America has been spared a re-run of the protracted election of 2000, its arms of government remain divided, with the Democrats holding onto their majority in the Senate and the Republicans in control of the House of Representatives. That could still lead to a logjam in policymaking, not least over the parlous state of the country’s public finances, and that’s unsettled investors.


In Europe, stocks gave up their morning gains. The FTSE 100 index of leading British shares was down 0.2 percent at 5,872 while Germany‘s DAX fell 0.4 percent to 7,358. The CAC-40 in France was 0.4 percent lower at 3,465.


Wall Street was poised for a retreat too in contrast to earlier predictions, with both Dow futures and the broader S&P 500 futures down 0.7 percent.


The most pressing matter facing the U.S. government is the so-called “fiscal cliff” — a combination of higher taxes and government spending cuts that automatically take effect unless Congress agrees on a new budget by Jan. 1. Economists warn that a failure to reach a concrete decision will push the world’s largest economy back into recession.


“The initially favorable reaction has evaporated with the ugly task of dealing with the fiscal cliff eclipsing earlier optimism,” said Andrew Wilkinson, chief economic strategist at Miller Tabak & Co.


Sentiment has also been hit by a downbeat set of European economic forecasts from the European Commission. The executive arm of the European Union now expects the 17-country eurozone to contract by 0.4 percent this year and to grow by only 0.1 percent next.


The turnaround in stocks markets was evident in currencies too— when risk appetite wanes, the dollar usually finds support. By early afternoon London time, the euro was 0.4 percent lower at $ 1.2754, a full cent lower than where it had been trading earlier.


Investors are also turning their gaze towards a crucial vote in the Greek Parliament later. If lawmakers don’t back a €13.5 billion ($ 17.3 billion) package of spending cuts and tax increases, the country faces the prospect of losing access to its bailout lifeline and potentially defaulting on its mountain of debt and leaving the euro.


That toxic combination could have massive negative repercussions in financial markets, regardless of whether a bipartisan budget solution is reached in the U.S. in the coming weeks.


“Strange to think that over 100 million votes cast in the U.S. may have less impact upon the markets over the next month or so than some 300 votes due to be cast in the Greek parliament this evening,” said Gary Jenkins, managing director of Swordfish Research.


Earlier in Asia, Japan‘s Nikkei 225 index closed marginally lower at 8,972.89. Hong Kong‘s Hang Seng added 0.7 percent to 22,099.85. South Korea‘s Kospi gained 0.5 percent to 1,937.55.


Mainland Chinese shares edged lower, with Shanghai Composite Index slipping marginally to 2,105.73. The smaller Shenzhen Composite Index lost 0.2 percent to 851.64


Also on investors’ radar is Thursday’s opening of China‘s Communist Party congress — the once-in-a-decade forum to name China’s top leadership. Although current Vice President Xi Jinping is almost certain to be China’s next leader, markets will be looking for hints on how the new leadership plans to tackle the nation’s economic slowdown.


In the oil markets, a price of benchmark New York crude was down $ 1.21 to $ 87.51 per barrel in electronic trading on the New York Mercantile Exchange.


Economy News Headlines – Yahoo! News



Read More..

Canada firms to capitalize on nuclear trade with India
















NEW DELHI (Reuters) – Canadian firms will be able to export uranium and nuclear reactors to India for the first time in almost four decades under an agreement between the two nations, their prime ministers said, but more work is needed to implement the deal.


Once implemented, the agreement will end a ban on nuclear cooperation Canada imposed in 1976 after India secretly exploded its first nuclear bomb in 1974, commonly called the “Smiling Buddha”, using material from a Canadian-built reactor in India.













“Being able to resolve these issues and move forward is, we believe, a really important economic opportunity for an important Canadian industry, part of the energy industry, that should pay dividends in terms of jobs and growth for Canadians down the road,” Canadian Prime Minister Stephen Harper said on Tuesday on a visit to New Delhi.


A negotiator with the Canadian Nuclear Safety Commission (CNSC), speaking on condition of anonymity because of the delicacy of the talks, said that what remained was a careful legal review of the language; translation into French and Hindi; and then a signing.


This is not expected to take very long, he said. The two sides have set up a joint committee to liaise on nuclear issues, but he said it would not be negotiating.


India aims to lift its nuclear capacity to 63,000 MW in the next 20 years by adding nearly 30 reactors. The country currently operates 20 mostly small reactors at six sites with a capacity of 4,780 MW, or 2 percent of its total power capacity, according to the Nuclear Power Corporation of India Limited.


Canada’s ambassador to India, Stewart Beck, said on Monday his country wanted to be able to track all nuclear material, but that India felt it only needed to report to the International Atomic Energy Agency (IAEA).


It was not clear who made concessions in the talks and how effective the safeguards would be to ensure that Canadian material did not get used again for making nuclear weapons.


However, the CNSC official said India would now be required to notify Canada of any transfers to a third country and trade could only go to facilities that are safeguarded by the IAEA.


PROBABLY BEATING AUSTRALIA


Harper said the CNSC had worked to “achieve all of our objectives in terms of non-proliferation”.


Canada is in a race against Australia, its strategic ally but a commercial rival in the uranium business. Australia is also trying to nail down safeguards under which it too could sell uranium to India.


“We are effectively ahead of the Australians,” the CNSC official said, noting however that Russia and Kazakhstan were already supplying into India.


Opening up the Indian market would be a big help to Canada’s Cameco Corp, which is the world’s largest publicly traded uranium producer but which recently cut its long-term output targets due to the Fukushima disaster.


“Anytime we can reduce the roadblocks to selling our product around the world is always helpful,” Cameco chief executive Tim Gitzel told Reuters in Canada. “It opens a new market for us with the appropriate safeguards in place. So this is good news.”


Another potential beneficiary is Canadian engineering firm SNC Lavalin Group Inc, which bought the government’s commercial nuclear division, which designed the Candu reactor that is in use in numerous countries.


“As far as the sales of reactors goes, we would normally now request that Canada be accorded the same treatment as the Russians, the French and the Americans and that a site be designated in India for the implementation of at least a twin- unit Candu nuclear power station,” SNC Lavalin International President Ronald Denom, part of Harper’s delegation in India, told Reuters.


He also said it should open up the market to service the existing reactors in India.


Harper also said Canada welcomed foreign investment, after the country temporarily blocked Malaysian state oil firm Petronas’ C$ 5.17 billion ($ 5.19 billion) bid for gas producer Progress Energy Resources on October 20.


Late on Friday, Canada extended to December 10 its review of a $ 15.1 billion bid made in July by China’s CNOOC Ltd for Canadian energy producer Nexen Inc.


“Those decisions have to be taken looking at the global evolving economy in which we operate,” Harper said.


($ 1 = C$ 0.9965)


(Additional reporting by Julie Gordon in Toronto; Additional writing by Frank Jack Daniel; Editing by Jonathan Thatcher and Michael Roddy)


Canada News Headlines – Yahoo! News



Read More..

Princess Leia Learns to Be a Disney Princess [VIDEO]


















Read More..

American composer Elliott Carter dies at age 103
















(Reuters) – Classical composer Elliott Carter, who twice won Pulitzer Prizes in a career that spanned more than 75 years, died on Monday in New York at age 103, music publisher Boosey & Hawkes said.


Carter was awarded Pulitzer Prizes in 1960 and 1973 for string quartet compositions. He composed 158 works, including several at over 100 years of age. One composition for chamber orchestra is scheduled for a world premier in February.













“The great range and diversity of his music has, and will continue to have, influence on countless composers and performers worldwide,” the publisher said. “He will be missed by us all but remembered for his brilliance, his wit and his great canon of work.”


He was inducted into the American Classical Music Hall of Fame in 1998 and celebrated his 100th birthday at New York‘s Carnegie Hall in 2008 with a new work performed by the Boston Symphony Orchestra.


Carter was presented the National Medal of Arts, the highest award given to artists by the United States, in 1985. He also received national honors from Germany and France.


(Reporting by David Bailey; Editing by Cynthia Johnston and Mohammad Zargham)


Music News Headlines – Yahoo! News



Read More..

St Jude device lowers blood pressure in small study
















(Reuters) – St Jude Medical Inc said on Monday its procedure that deadens nerves near the kidneys helped lower blood pressure in a small study of patients whose hypertension could not be controlled with drugs.


Patients in the study who were treated with the Enlightn renal denervation system saw an average reduction of 28 points in systolic blood pressure, which is the first number expressed in a reading, after 30 days. At six months, the 46 patients who received the treatment maintained an average systolic blood pressure reduction of 26 mmHg points.













The results were presented at the annual meeting of the American Heart Association in Los Angeles.


Patients enrolled in the study had an average blood pressure of 176/96 mmHg despite being treated with multiple medications to manage the condition. No serious side effects were reported, St Jude said.


Normal blood pressure is below 120/80 mmHg. Hypertension, or high blood pressure, is a reading above 140/90 mmHg.


Renal denervation is a procedure in which a thin, flexible catheter is threaded through the body to the renal sympathetic nerves near the kidneys. Radiofrequency energy is delivered to disrupt the nerve activity, relieving high blood pressure.


Millions of people have hypertension that is resistant to drugs, putting them at risk of heart attacks and stroke.


The new therapy is not yet approved in the United States, but several products are already available in Europe.


Device makers that have already received approval to sell hypertension devices in Europe include Medtronic, the front-runner, St Jude, Covidien, ReCor Medical and Vessix Vascular.


St Jude shares were up 29 cents, or less than 1 percent, at $ 38.80 in afternoon trading on the New York Stock Exchange.


(Reporting By Susan Kelly and Debra Sherman in Chicago; Editing by Gerald E. McCormick, Leslie Adler and Jim Marshall)


Medications/Drugs News Headlines – Yahoo! News



Read More..

Ahead of the Bell: Express Scripts plummets
















NEW YORK (AP) — Shares of Express Scripts slid in premarket trading Tuesday after the pharmacy benefits manager warned that persistent high joblessness and economic uncertainty would make 2013 more challenging, and expectations of Wall Street analysts were too high.


Pharmacy benefits managers, or PBMs, run prescription drug plans for employers, insurers and other customers. They process mail-order prescriptions and handle bills for prescriptions filled at retail pharmacies.













The St. Louis company handles more than a billion prescriptions each year after the $ 29.1 billion acquisition of a rival, Medco, in April.


Analysts were disappointed by the company’s outlook. Investors will now question whether Express Scripts benefits as much from recent acquisitions as the company had led them to believe, said Citi analyst George Hill, calling the company’s forecast “baffling.”


Express Scripts had lifted its 2012 earnings forecast in August after recording better-than-expected savings from its combination with Medco.


Jefferies analyst Brian Tanquilut lowered his rating on Express Scripts to “Hold” from “Buy” and cut his price target on the shares by $ 14 to $ 56.


Shares of Express Scripts Holding Co. dropped $ 8.25, or 13 percent, to $ 54.63 before the opening bell. The stock was up 41 percent so far this year through Monday’s trading.


Economy News Headlines – Yahoo! News



Read More..